Welcome to Idorsia
https://www.idorsia.comIdorsia Pharmaceuticals Ltd. Tue Dec 21 12:00:08 CET 2021. The impact of insomnia is often underestimated. In reality, it can be a distressing condition that can reduce quality of life. It may affect many aspects of daily life, from studying and employment to …
Novartis
https://www.novartis.comNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Actelion - Wikipedia
https://en.wikipedia.org/wiki/ActelionActelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.. Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases.Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart …
Effects of Adaptogens on the Central Nervous System and the ...
www.ncbi.nlm.nih.gov › pmc › articlesJan 19, 2010 · The adaptogens Eleutherococcus senticosus, Rhodiola rosea and Schisandra chinensis were reported to be safe in acute and subacute toxicity studies. Moreover, adaptogen induced state of non-specific resistance to highly toxic chemicals (e.g., chlorophos, phosphorus, cyclophosphane, strychnine, aniline, sodium nitrite, narcotics like sodium barbital, hexenal, chloralhydrate, benzene, acetone ...
Pharmaceuticals | About - MDPI
https://www.mdpi.com/journal/pharmaceuticals/aboutPharmaceuticals (ISSN 1424-8247) is an international scientific journal of medicinal chemistry and related drug sciences. Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details. Short communications are also accepted; therefore, there is no restriction on the length of a paper.
Basel, Switzerland | Lonza
https://pharma.lonza.com/about/locations/basel-switzerlandBasel operates under the global quality management system which complies with internal policies as well as with national and international regulations. Since receiving the GMP certificate in 2017, Lonza Drug Product Services has had multiple successful inspections from health authorities, in addition to successful customer and self-inspections.